30 Stocks Moving In Friday's Mid-Day Session

Gainers

• Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) shares climbed 32.9 percent to $0.835. Roth Capital assumed Cyclacel Pharmaceuticals with a Buy rating and a price target of $8.
• DGSE Companies, Inc. (NYSE:DGSE) gained 22.2 percent to $0.55 on continued momentum after Corrent Resources, a subsidiary of DGSE Companies, announced it has completed the purchase of demanufacturing and IT-asset-disposition assets of Echo Environmental and ITAD USA.
• Hibbett Sports, Inc. (NASDAQ:HIBB) jumped 21.2 percent to $24.03 after reporting upbeat earnings for its fourth quarter.
• Cavco Industries, Inc. (NASDAQ:CVCO) gained 15.1 percent to $156.62 after the company posted upbeat Q4 results.
• Total System Services, Inc. (NYSE:TSS) shares rose 9.9 percent to $109.40 following a Bloomberg report that the company is in talks with Global Payments Inc (NYSE:GPN) about a potential merger.
• CEL-SCI Corporation (NYSE:CVM) gained 9.7 percent to $5.04.
• Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) jumped 9.3 percent to $4.10.
• Aphria Inc. (NYSE:APHA) gained 8.5 percent to $6.95. Jefferies initiated coverage on Aphria ith a Buy rating.
• ViaSat, Inc. (NASDAQ:VSAT) gained 8 percent to $94.84 after the company reported Q4 EPS up from last year and better-than-expected sales results.
• Santander Consumer USA Holdings Inc (NYSE:SC) gained 7.9 percent to $22.25 after the company announced a $400 million buyback during Q2.
• ZAGG Inc (NASDAQ:ZAGG) gained 7.2 percent to $6.99.
• Molecular Templates, Inc. (NASDAQ:MTEM) rose 7.2 percent to $8.35.
• TherapeuticsMD, Inc. (NASDAQ:TXMD) gained 6.5 percent to $3.28.
• ICICI Bank Limited (NYSE:IBN) shares rose 6.4 percent to $12.39.
• Cytokinetics, Incorporated (NASDAQ:CYTK) shares gained 6.4 percent to $10.19.
• Deckers Outdoor Corporation (NYSE:DECK) rose 5.5 percent to $155.31 after reporting better-than-expected results for its fourth quarter.
• NovoCure Limited (NASDAQ:NVCR) rose 6 percent to $52.26. Novocure said the FDA has approved the NovoTTF-100L System in combination with pemetrexed plus platinum-based chemotherapy for the first-line treatment of unresectable, locally advancedor metastatic pleural mesothelioma, or MPM — a cancer of the pleura, the protective lining of the lung.
• HP Inc (NYSE:HPQ) rose 4.2 percent to $19.99. HP reported stronger-than-expected Q2 results and narrowed FY19 EPS guidance on the high-end of analyst estimates.

Check out these big penny stock gainers and losers

Losers

• Urban Tea, Inc. (NASDAQ:MYT) tumbled 49.6 percent to $1.20 after the company announced a direct offering of its ordinary shares worth approximately $4.6 million.
• Foot Locker, Inc. (NYSE:FL) shares fell 16.9 percent to $43.91 after the company reported downbeat results for its first quarter.
• Diffusion Pharmaceuticals Inc (NASDAQ:DFFN) dipped 16.1 percent to $4.00 after the company announced a direct offering of 1.3 million shares priced at $4.77 per share.
• Intelligent Systems Corporation (NYSE:INS) dropped 10.5 percent to $35.00 on bearish article published by Aurelius Value called 'INS: A Wolf in Pete's Clothing.'
• DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI) dipped 8.9 percent to $2.05.
• Maxar Technologies Inc. (NYSE:MAXR) shares declined 8.3 percent to $8.12.
• S&W Seed Company (NASDAQ:SANW) dropped 7.5 percent to $2.72.
• Lions Gate Entertainment Corp. (NYSE: LGF-A) shares dropped 7.2 percent to $14.84 following Q4 results.
• Taitron Components Incorporated (NASDAQ:TAIT) fell 7.1 percent to $3.02.
• Aquestive Therapeutics, Inc. (NASDAQ:AQST) dropped 6.5 percent to $4.2150.
• Splunk Inc. (NASDAQ:SPLK) fell 6.4 percent to $120.56 following Q1 results.
• Autodesk, Inc. (NASDAQ:ADSK) fell 5.9 percent to $159.60 after the company reported weaker-than-expected results for its first quarter on Thursday.